Fachliteratur Gastroenterologie: Neoplasien Pankreas

Fr | De

Feedback | Impressum | Sitemap

Keine Artikel ausgewählt!

Warenkorb

Sie sind hier: Fachliteratursuche » Pankreas » Neoplasie

30. Dezember 2025

Abklärungen / Diagnostik

Therapien

Guidelines

Fortbildung

News / Journalscreening

Schrift:

Seite 1 von 2931


	Artikel 1 - 20 / 58609

	Deep learning based on ultrasound for differential diagnosis of pancreatic serous cystic neoplasm and mucinous cystic neoplasm. BMC Cancer Yuan Z, Shi Y, Chen S, Yang J, Chen J, Li J, Pu Y, Ma X, Yang Q, Zhao X, Mou L, Shi Y, Luo Y. PMID: 41466236 [PubMed - in process]
	Skeletal muscle mass associates with pancreaticoduodenectomy operative time in a sex-dependent manner. BMC Cancer Xiao S, Freeman A, Kalmanek E, Steckly K, Belding-Schmitt M, Chan CHF, Talbert EE. PMID: 41466196 [PubMed - indexed for MEDLINE]
	Prognostic Value of CONUT and ALBI in Metastatic Pancreatic Cancer: A Retrospective Cohort Study. Diagnostics (Basel) Peker P, Geçgel A, Y, C, Selvi S, Bozkurt Duman B, Çil T. PMID: 41464163 [PubMed]
	Advances and Challenges in Drug Screening for Cancer Therapy: A Comprehensive Review. Bioengineering (Basel) Motohashi S, Katsuta E, Ban D. PMID: 41463612 [PubMed]
	Insulin Resistance at the Crossroads of Metabolic Inflammation, Cardiovascular Disease, Organ Failure and Cancer. Biomolecules Lonardo A, Weiskirchen R. PMID: 41463398 [PubMed - indexed for MEDLINE]
	Single-Cell Sequencing Unravels Pancreatic Cancer: Novel Technologies Reveal Novel Aspects of Cellular Heterogeneity and Inform Therapeutic Strategies. Biomedicines Chen K, Chen Z, Wang J, Zhou M, Liu Y, Xu B, Yu Z, Li Y, Yang G, Xu T. PMID: 41463034 [PubMed]
	Post-Translational Modifications: Key "Regulators" of Pancreatic Cancer Malignant Phenotype-Advances in Mechanisms and Targeted Therapies. Biomedicines Shi Y, Qin R, Li Y. PMID: 41463025 [PubMed]
	Stromal COL11A1: Mechanisms of Stroma-Driven Multidrug Resistance in Breast Cancer and Biomarker Potential. Biomedicines Onofrei Popa A, Mihailuta F, Mihalache D, Vod, Jurja S, Deacu S, Mehedin. PMID: 41462920 [PubMed]
	The Redox-Adhesion-Exosome (RAX) Hub in Cancer: Lipid Peroxidation-Driven EMT Plasticity and Ferroptosis Defense with HNE/MDA Signaling and Lipidomic Perspectives. Antioxidants (Basel) Park MN, Choi J, Ribeiro RIMA, Delfino DV, Ko SG, Kim B. PMID: 41462674 [PubMed]
	Analysis of the predictive effect of gut microbiota changes on the occurrence of chemotherapy resistance in pancreatic cancer patients based on nomogram prediction models. BMC Cancer Li Y, Liu S, Lai X, Yang D. PMID: 41462440 [PubMed - indexed for MEDLINE]
	Urine-based nematode chemotaxis assay (N-NOSE) as a predictor of recurrence after curative surgery for resectable pancreatic cancer: preliminary data and single center experience. BMC Surg Fukada M, Mitsui N, Horaguchi T, Yasufuku I, Sato Y, Tajima JY, Tanaka Y, Hatakeyama H, Alshammari AH, Morishita M, Hirotsu T, di Luccio E, Futamura M, Matsuhashi N. PMID: 41462185 [PubMed - indexed for MEDLINE]
	Impact of electronic patient-reported outcomes (ePRO) presentation in pancreatic cancer tumor board discussions on cancer outcomes: the INSPIRE intervention. BMC Cancer Bourne G, Henderson N, El Dick J, Deng L, Franks J, Williams CP, Pywell C, Rose JB, Williams GR, Qasim Hussaini SM, Nipp RD, Rocque G. PMID: 41462170 [PubMed - as supplied by publisher]
	Prognostic significance of reduced handgrip strength in patients with unresectable hepatocellular carcinoma receiving HAIC combined with targeted immunotherapy. Front Immunol Wang XZ, Wang P, Lv X, Zhang ZL, Zhang EL, Ji GB. PMID: 41459515 [PubMed - indexed for MEDLINE]
	The Prophylactic Role of Hyperthermic Intraperitoneal Chemotherapy on Spontaneously Ruptured Hepatocellular Carcinoma with Radical Resection: A Retrospective Study. Cancer Manag Res Li Z, Lin J, Gao K, Dang X, Hua Y. PMID: 41459137 [PubMed]
	Associations Between Gastroenteropancreatic Neuroendocrine Neoplasms and Inflammatory Factors: Insights From a Two-Sample Mendelian Randomization Analysis. Can J Gastroenterol Hepatol Guo H, Li Y, Liu B, Liu S. PMID: 41458898 [PubMed - indexed for MEDLINE]
	Efficacy of TACE plus tyrosine kinase inhibitors and immune checkpoint inhibitors in patients with unresectable hepatocellular carcinoma: a systematic review and meta-analysis. Front Oncol Ye K, Zhou J, Lin J, Li Y, Luo Y, Xie F. PMID: 41458593 [PubMed]
	Metabolic signatures in gastroenteropancreatic neuroendocrine neoplasms: unraveling diagnostic and prognostic insights. Front Endocrinol (Lausanne) de Lima-Souza RA, Maciel TF, Gonçalves MWA, Ribeiro FCP, Maioral RA, Scarini JF, Soraes HP, Fillmore GC, Egal ESA. PMID: 41458541 [PubMed - indexed for MEDLINE]
	The Role of RANBP3L in Pan-Cancer With Its Significance in Hepatocellular Carcinoma. Cancer Rep (Hoboken) Cen B, Li J, Wang C. PMID: 41457788 [PubMed - indexed for MEDLINE]
	MTAP in small biopsy samples of pancreatic lesions: a potential diagnostic biomarker. Immunohistochemical, fluorescence in situ hybridization and molecular analysis. Pathologica Lucà S, Salzillo C, Masola V, De Vita F, Porpora D, Conzo G, Savarese G, Sirica R, Cozzolino I, Clery E, Zito Marino F, Franco R, Montella M. PMID: 41454767 [PubMed - indexed for MEDLINE]
	High E2F7 Expression Indicates Pancreatic Cancer Aggressiveness and Downregulation of E2F7 Enhances Sensitivity to S-1. Ann Surg Oncol Fujita K, Okamura Y, Hayashi M, Ashida R, Otsu T, Sakai A, Mii S, Sugimoto M, Yamamoto N, Toyama H, Maeda A, Mizuno N, Yokoyama Y, Yamaguchi J, Nakagawa N, Kurimoto K, Tanaka H, Takami H, Enomoto A, Uesaka K, Kanda M. PMID: 41454190 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 58609

Seite 1 von 2931



		Zeitfenster

Ironmedline

Das Fachportal für Eisenmangel >>

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung